Harrison Widelitz

home / authors / harrison-widelitz

Articles

Data from CCTG HE1 also show a numerical improvement an in overall survival with added radiotherapy over best supportive care alone.

Single-Fraction Radiotherapy Improves Pain in Hepatic Cancer

Harrison Widelitz
September 16th 2024

Data from CCTG HE1 also show a numerical improvement an in overall survival with added radiotherapy over best supportive care alone.

Research shows that patients with pancreatic ductal adenocarcinoma are frequently understaged prior to surgery.

Initial Staging for PDAC Yields Inaccuracies

Harrison Widelitz
September 11th 2024

Research shows that patients with pancreatic ductal adenocarcinoma are frequently understaged prior to surgery.

The use of 5-fluorouracil decreased toxicity and possible savings in first-line advanced gastrointestinal cancers.

Omission of 5-FU From Combo Therapy May Improve Results in Advanced GI Cancers

Harrison Widelitz
September 9th 2024

The use of 5-fluorouracil decreased toxicity and possible savings in first-line advanced gastrointestinal cancers.

Recent FDA approvals of the companion diagnostics may help improve personalized treatment decision-making for patients with prostate cancer.

FDA Approves FoundationOne Tests for Olaparib Combo in BRCA-Mutated mCRPC

Harrison Widelitz
September 5th 2024

Recent FDA approval of the companion diagnostics may help improve personalized treatment decision-making for patients with prostate cancer.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
45-Year-Old Female With Gross Hematuria Post Partial Nephrectomy
Published: March 1st 2018 | Updated: September 16th 2024
45-Year-Old Female With Gross Hematuria Post Partial Nephrectomy
Neonate With a Soft, Yellowish-Colored Plaque on the Temple
Published: July 16th 2011 | Updated: September 16th 2024
Neonate With a Soft, Yellowish-Colored Plaque on the Temple
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
Published: May 17th 2013 | Updated: September 16th 2024
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer